Uniqure søger en
Vice President, Corporate Income Tax
Amsterdam, Netherlands
At uniQure, we are delivering on the promise of gene therapy and delivering hope for patients facing urgent unmet medical needs. Every role in our organization carries profound purpose; whether you're in research, operations, access, or support, your contributions impact patients. We're seeking passionate professionals who thrive in high-stakes environments, uphold rigorous quality standards, and share our relentless commitment to transforming the lives of patients. Join us in making the impossible possible, where your expertise becomes a catalyst for life-changing treatments.
Job Purpose
uniQure is establishing a standalone corporate income tax function. The VP, Corporate Income Tax leads this function across the group's operating footprint (Netherlands, United States as well as operations in France, the United Kingdom and Switzerland). The role is accountable for the group's corporate income tax strategy, planning, compliance, transfer pricing, controversy and risk management, and for partnering closely with the Technical Accounting function on tax reporting.
uniQure is preparing for a pivotal transition from a development-stage to a commercial group. Following potential BLA approval in the US and MAA approval in the UK in 2027, uniQure will begin commercializing its products, and subsequently intends to launch in further territories — such as the Middle East and Latin America — through third-party distributors. Working in close cooperation with the business, the VP plays a central role in building the commercial and cross-border operating model tax-efficiently, structuring distributor and commercial arrangements, managing the resulting jurisdictional and transfer pricing complexity, and supporting the CFO in defining and executing the group's tax strategy through this growth.
Key Result Areas — Major Duties, Accountabilities and Responsibilities
1. Tax strategy and planning
Support the CFO in defining the group's long-term corporate income tax strategy, aligned with business objectives, corporate structure and growth plans. Accountable for translating that long-term strategy into executable strategic and operational plans — developing and recommending tax-efficient structures for R&D, IP ownership and licensing, intercompany financing, and the commercial and distributor model, and driving their implementation. Advise on the tax consequences of strategic, transactional and operational decisions, and contribute to management of the group's effective tax rate (ETR) and cash tax position.
2. Tax accounting and reporting (close contribution; owned by Director Technical Accounting)
Partner closely with the Director Technical Accounting on the quarterly and annual income tax provision (ASC 740 / IAS 12 as applicable), deferred taxes, valuation allowances and uncertain tax positions. Provide the underlying analysis, jurisdictional data, planning inputs and technical positions needed for accurate provisioning, SEC/statutory disclosures, SOX-related controls and the external audit. Ensure alignment between tax planning and tax accounting outcomes.
3. Compliance and reporting
Own timely and accurate filing of all corporate income tax returns across the group's jurisdictions (US federal and state, Netherlands, France, UK, Switzerland). Ensure compliance with evolving requirements, including BEPS 2.0 / Pillar Two global minimum tax and country-by-country reporting. Accountable for no material penalties or late filings.
4. Transfer pricing
Design, document and defend the group's transfer pricing policies for intercompany transactions (IP, R&D, services, financing and the future distribution/commercial flows), consistent with OECD guidelines and local rules. Maintain master file, local files and intercompany agreements, and manage transfer pricing risk.
5. Tax audits, controversy and risk management
Manage relationships with tax authorities and lead the defense of audits, disputes and rulings across jurisdictions. Maintain the group's tax risk framework and reserve positions, resolving matters with minimized financial exposure.
6. Incentives, credits and cash optimization
Identify and secure corporate income tax incentives relevant to a biotech/gene therapy group — for example the Dutch Innovation Box and applicable R&D and orphan drug credits — and support the group's cash tax, funding and repatriation strategy.
7. Commercial launch and distributor-model readiness
Assess and prepare for the tax implications of the 2027 commercial launch and third-party distributor arrangements, including nexus/permanent-establishment considerations, withholding taxes, contract structuring, and the transfer pricing and profit-attribution consequences of moving from a development-stage to a commercial group.
8. Forecasting and business partnering
Provide income tax forecasts, ETR modeling and scenario analysis to support budgeting, guidance and strategic decisions. Partner with FP&A, Treasury, Legal, Accounting and business units as the group's subject-matter expert on corporate income tax.
9. Governance, policy and external advisors
Establish and maintain the group's tax policy and governance framework for the newly standalone function. Manage external tax advisors and support to auditors, controlling cost and quality, and monitor legislative and regulatory developments for their impact on the group.
10. Function build and leadership
Establish, lead and develop the standalone corporate income tax function, including its operating model, processes and tools. Lead, set objectives for and develop the initial direct report, and plan for appropriate resourcing as the group scales.
Scope and Boundaries
Covers corporate income tax across all group jurisdictions. Does not cover VAT/indirect tax or payroll/wage taxes. Tax accounting/provisioning is owned by the Director Technical Accounting, with the VP as a close contributor. Long-term tax strategy is defined with and owned at CFO level; the VP is accountable for translating it into executable plans and driving execution.
Required Qualifications and Experience
Key Competencies
Strategic and commercial thinking; strong technical tax expertise; sound judgment on risk; excellent communication with senior and non-tax stakeholders; cross-functional collaboration; hands-on and pragmatic in a lean, scaling environment; integrity and governance mindset; ability to build and lead a small team.
Job Purpose
uniQure is establishing a standalone corporate income tax function. The VP, Corporate Income Tax leads this function across the group's operating footprint (Netherlands, United States as well as operations in France, the United Kingdom and Switzerland). The role is accountable for the group's corporate income tax strategy, planning, compliance, transfer pricing, controversy and risk management, and for partnering closely with the Technical Accounting function on tax reporting.
uniQure is preparing for a pivotal transition from a development-stage to a commercial group. Following potential BLA approval in the US and MAA approval in the UK in 2027, uniQure will begin commercializing its products, and subsequently intends to launch in further territories — such as the Middle East and Latin America — through third-party distributors. Working in close cooperation with the business, the VP plays a central role in building the commercial and cross-border operating model tax-efficiently, structuring distributor and commercial arrangements, managing the resulting jurisdictional and transfer pricing complexity, and supporting the CFO in defining and executing the group's tax strategy through this growth.
Key Result Areas — Major Duties, Accountabilities and Responsibilities
1. Tax strategy and planning
Support the CFO in defining the group's long-term corporate income tax strategy, aligned with business objectives, corporate structure and growth plans. Accountable for translating that long-term strategy into executable strategic and operational plans — developing and recommending tax-efficient structures for R&D, IP ownership and licensing, intercompany financing, and the commercial and distributor model, and driving their implementation. Advise on the tax consequences of strategic, transactional and operational decisions, and contribute to management of the group's effective tax rate (ETR) and cash tax position.
2. Tax accounting and reporting (close contribution; owned by Director Technical Accounting)
Partner closely with the Director Technical Accounting on the quarterly and annual income tax provision (ASC 740 / IAS 12 as applicable), deferred taxes, valuation allowances and uncertain tax positions. Provide the underlying analysis, jurisdictional data, planning inputs and technical positions needed for accurate provisioning, SEC/statutory disclosures, SOX-related controls and the external audit. Ensure alignment between tax planning and tax accounting outcomes.
3. Compliance and reporting
Own timely and accurate filing of all corporate income tax returns across the group's jurisdictions (US federal and state, Netherlands, France, UK, Switzerland). Ensure compliance with evolving requirements, including BEPS 2.0 / Pillar Two global minimum tax and country-by-country reporting. Accountable for no material penalties or late filings.
4. Transfer pricing
Design, document and defend the group's transfer pricing policies for intercompany transactions (IP, R&D, services, financing and the future distribution/commercial flows), consistent with OECD guidelines and local rules. Maintain master file, local files and intercompany agreements, and manage transfer pricing risk.
5. Tax audits, controversy and risk management
Manage relationships with tax authorities and lead the defense of audits, disputes and rulings across jurisdictions. Maintain the group's tax risk framework and reserve positions, resolving matters with minimized financial exposure.
6. Incentives, credits and cash optimization
Identify and secure corporate income tax incentives relevant to a biotech/gene therapy group — for example the Dutch Innovation Box and applicable R&D and orphan drug credits — and support the group's cash tax, funding and repatriation strategy.
7. Commercial launch and distributor-model readiness
Assess and prepare for the tax implications of the 2027 commercial launch and third-party distributor arrangements, including nexus/permanent-establishment considerations, withholding taxes, contract structuring, and the transfer pricing and profit-attribution consequences of moving from a development-stage to a commercial group.
8. Forecasting and business partnering
Provide income tax forecasts, ETR modeling and scenario analysis to support budgeting, guidance and strategic decisions. Partner with FP&A, Treasury, Legal, Accounting and business units as the group's subject-matter expert on corporate income tax.
9. Governance, policy and external advisors
Establish and maintain the group's tax policy and governance framework for the newly standalone function. Manage external tax advisors and support to auditors, controlling cost and quality, and monitor legislative and regulatory developments for their impact on the group.
10. Function build and leadership
Establish, lead and develop the standalone corporate income tax function, including its operating model, processes and tools. Lead, set objectives for and develop the initial direct report, and plan for appropriate resourcing as the group scales.
Scope and Boundaries
Covers corporate income tax across all group jurisdictions. Does not cover VAT/indirect tax or payroll/wage taxes. Tax accounting/provisioning is owned by the Director Technical Accounting, with the VP as a close contributor. Long-term tax strategy is defined with and owned at CFO level; the VP is accountable for translating it into executable plans and driving execution.
Required Qualifications and Experience
- Degree in Tax, Law, Accounting, Economics or Finance; advanced tax qualification (e.g. Dutch tax advisor, German “Steuerberater”, JD/LLM in tax, or equivalent).
- Extensive corporate income tax experience gained in a multinational and/or Big Four environment, including international/cross-border tax.
- Strong knowledge of US and Netherlands corporate tax; familiarity with UK, French and Swiss tax an advantage.
- Practical experience with transfer pricing and with BEPS 2.0 / Pillar Two.
- Working knowledge of tax accounting (ASC 740 / IAS 12) sufficient to partner effectively with Technical Accounting; SEC-registrant/listed-company experience preferred.
- Life sciences / pharma / biotech experience and exposure to a commercial launch or distributor model desirable.
- Experience building or standing up a tax function or process preferred.
Key Competencies
Strategic and commercial thinking; strong technical tax expertise; sound judgment on risk; excellent communication with senior and non-tax stakeholders; cross-functional collaboration; hands-on and pragmatic in a lean, scaling environment; integrity and governance mindset; ability to build and lead a small team.